Ventyx Gross Profit from 2010 to 2024

VTYX Stock

USD 1.73 0.01 0.58%

Ventyx Biosciences Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Ventyx Biosciences makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

-941 K

Current Value

-894 K

Quarterly Volatility

321 K

Credit Downgrade

Yuan Drop

Covid

Check Ventyx Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ventyx Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 15.4 M, Depreciation And Amortization of 150.1 K or Interest Expense of 5.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.62. Ventyx financial statements analysis is a perfect complement when working with Ventyx Biosciences Valuation or Volatility modules.

Check out the analysis of Ventyx Biosciences Correlation against competitors.

For more information on how to buy Ventyx Stock please use our How to Invest in Ventyx Biosciences guide.

Latest Ventyx Biosciences' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Ventyx Biosciences over the last few years. Gross profit is a required income statement account that reflects total revenue of Ventyx Biosciences minus its cost of goods sold. It is profit before Ventyx Biosciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Ventyx Biosciences' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ventyx Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Ventyx Gross Profit Regression Statistics

	Arithmetic Mean	(177,663)
	Coefficient Of Variation	(180.70)
	Mean Deviation	236,261
	Median	(30,000)
	Standard Deviation	321,032
	Sample Variance	103.1B
	Range	911K
	R-Value	(0.68)
	Mean Square Error	59.3B
	R-Squared	0.47
	Significance	0.01
	Slope	(48,977)
	Total Sum of Squares	1.4T

Ventyx Gross Profit History

	2024	-894 K
	2023	-941 K
	2022	-470 K

Other Fundumenentals of Ventyx Biosciences

Gross Profit Margin

Ventyx Biosciences Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Net Receivables	Capital Surpluse	Common Stock	Property Plant Equipment	Short Term Debt
Total Assets		-0.02	0.71	-0.97	-0.81	0.99	0.82	0.6	1.0	1.0	1.0	0.52	0.78	0.74	0.79	0.5
Total Stockholder Equity	-0.02		0.48	0.07	-0.55	0.06	0.06	0.38	-0.05	0.01	-0.01	0.83	0.41	0.54	0.38	0.85
Net Tangible Assets	0.71	0.48		-0.58	-0.93	0.76	0.56	0.64	0.69	0.71	0.71	0.84	0.94	0.96	0.94	0.83
Net Debt	-0.97	0.07	-0.58		0.73	-0.94	-0.75	-0.47	-0.98	-0.97	-0.97	-0.45	-0.64	-0.62	-0.65	-0.43
Retained Earnings	-0.81	-0.55	-0.93	0.73		-0.86	-0.73	-0.76	-0.78	-0.82	-0.81	-0.92	-0.92	-0.96	-0.92	-0.91
Accounts Payable	0.99	0.06	0.76	-0.94	-0.86		0.87	0.7	0.98	0.99	0.99	0.59	0.84	0.81	0.85	0.57
Long Term Debt	0.82	0.06	0.56	-0.75	-0.73	0.87		0.9	0.8	0.83	0.83	0.5	0.7	0.67	0.7	0.49
Total Liab	0.6	0.38	0.64	-0.47	-0.76	0.7	0.9		0.55	0.61	0.6	0.67	0.73	0.74	0.72	0.67
Net Invested Capital	1.0	-0.05	0.69	-0.98	-0.78	0.98	0.8	0.55		1.0	1.0	0.49	0.76	0.72	0.77	0.47
Total Current Assets	1.0	0.01	0.71	-0.97	-0.82	0.99	0.83	0.61	1.0		1.0	0.54	0.8	0.76	0.8	0.52
Net Working Capital	1.0	-0.01	0.71	-0.97	-0.81	0.99	0.83	0.6	1.0	1.0		0.53	0.79	0.75	0.79	0.51
Net Receivables	0.52	0.83	0.84	-0.45	-0.92	0.59	0.5	0.67	0.49	0.54	0.53		0.8	0.89	0.78	1.0
Capital Surpluse	0.78	0.41	0.94	-0.64	-0.92	0.84	0.7	0.73	0.76	0.8	0.79	0.8		0.99	1.0	0.78
Common Stock	0.74	0.54	0.96	-0.62	-0.96	0.81	0.67	0.74	0.72	0.76	0.75	0.89	0.99		0.98	0.88
Property Plant Equipment	0.79	0.38	0.94	-0.65	-0.92	0.85	0.7	0.72	0.77	0.8	0.79	0.78	1.0	0.98		0.77
Short Term Debt	0.5	0.85	0.83	-0.43	-0.91	0.57	0.49	0.67	0.47	0.52	0.51	1.0	0.78	0.88	0.77

Click cells to compare fundamentals

About Ventyx Biosciences Financial Statements

Ventyx Biosciences investors use historical fundamental indicators, such as Ventyx Biosciences' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Ventyx Biosciences. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Gross Profit	-941 K	-894 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Ventyx Stock Analysis

When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC